Evidence map›Paper›PMID 36982253›Full record

ArticleInternational journal of molecular sciences2023

Genetic Networks of Alzheimer's Disease, Aging, and Longevity in Humans.

Timothy Balmorez, Amy Sakazaki, Shin Murakami

Full text read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Investigation of the Potential Neuroprotective Mechanisms ofInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Molecular Mechanisms of Dementia 2.0.International journal of molecular sciences · 2024
    Article
  7. Microglial Transforming Growth Factor-β Signaling in Alzheimer's Disease.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Timothy BalmorezDepartment of Basic Sciences, College of Osteopathic Medicine, Touro University California, Vallejo, CA 94592, USA.
Amy SakazakiDepartment of Basic Sciences, College of Osteopathic Medicine, Touro University California, Vallejo, CA 94592, USA.
Shin MurakamiDepartment of Basic Sciences, College of Osteopathic Medicine, Touro University California, Vallejo, CA 94592, USA.ORCID 0000-0001-8806-0611

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human genomic analysis and genome-wide association studies (GWAS) have identified genes that are risk factors for early and late-onset Alzheimer's disease (AD genes). Although the genetics of aging and longevity have been extensively studied, previous studies have focused on a specific set of genes that have been shown to contribute to or are a risk factor for AD. Thus, the connections among the genes involved in AD, aging, and longevity are not well understood. Here, we identified the genetic interaction networks (referred to as pathways) of aging and longevity within the context of AD by using a gene set enrichment analysis by Reactome that cross-references more than 100 bioinformatic databases to allow interpretation of the biological functions of gene sets through a wide variety of gene networks. We validated the pathways with a threshold of

Indexed as

Alzheimer DiseaseGene Regulatory NetworksGenome-Wide Association StudyHumansInterleukin-13Interleukin-3Interleukin-13Interleukin-3age-related comorbiditycentenariandementiaepigeneticshallmark of aginglife extensionlongevity

Identifiers

PMID36982253
PMCPMC10049434

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read6
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.